News & Announcements
posted: April 25, 2019
On April 16, 2019, the U.S. Food and Drug Administration (FDA) issued an unexpected mandate recalling and halting the distribution of all remaining surgical mesh indicated for transvaginal (TV) repair of pelvic organ prolapse (POP), effective immediately.
posted: February 15, 2019
On February 12th 2019, the FDA convened a meeting of the Obstetrics and Gynecology Medical Device Advisory Committee in Washington, D.C. to specifically address the safety and effectiveness of surgical mesh for transvaginal repair of pelvic organ prolapse in the anterior vaginal compartment.
posted: February 12, 2019
SUFU Position Statement on Mesh Midurethral Slings (MUS) for Stress Urinary Incontinence (Updated February 2019)
posted: December 3, 2018
The AUA’s “Writing A Successful Career Development Award Application” course is written by NIH-funded urology researchers and will help prepare early-career investigators to write competitive grant applications.
posted: August 7, 2018
On July 30, 2018, the FDA posted a communication regarding the use of energy-based devices, including laser and radiofrequency, for vaginal cosmesis and “rejuvenation.”